Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000463937 | SCV000559305 | likely benign | Rhabdoid tumor predisposition syndrome 2 | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001017515 | SCV001178604 | likely benign | Hereditary cancer-predisposing syndrome | 2015-10-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV003168900 | SCV003915402 | uncertain significance | not provided | 2022-10-06 | criteria provided, single submitter | clinical testing | In silico analysis supports that this variant does not alter splicing; Has not been previously published as pathogenic or benign to our knowledge |